Newhall Charles W III (CIK 0001005544)

Latest company ownership

VIRX - Viracta Therapeutics, Inc.

Role: 10% Owner

Shares held

9,994,990

Last filed at

Jul 2, 2010

Confidence Score

50.0

2025Q4

Confidence Score History

2010Q2 2025Q4

SUPN - SUPERNUS PHARMACEUTICALS, INC.

Role: Director

Shares held

15,000

Last filed at

Nov 24, 2025

Confidence Score

24.5

2025Q4

Confidence Score History

2023Q4 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 9, 2025	Oct 10, 2025	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	15.0	-25,000	-19.28%	✓	$1.3M
Aug 27, 2025	Aug 29, 2025	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	41.3	-3,588	-2.69%	✓	$161.5K
Aug 25, 2025	Aug 27, 2025	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	51.3	-1,000	-0.74%	✓	$45K
Aug 22, 2025	Aug 26, 2025	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	45.0	-1,412	-1.04%	✓	$63.5K
Nov 11, 2024	Nov 12, 2024	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	20.0	-10,700	-7.59%	✗	$387.8K
Nov 16, 2023	Nov 20, 2023	SUPERNUS PHARMACEUTICALS, INC.	Director	Sell	22.5	-2,500	-2.09%	✗	$70K
Jun 30, 2010	Jul 2, 2010	Viracta Therapeutics, Inc.	10% Owner	Buy	100.0	+23,824,451	100.00%	✗	$6.6M